Prevalence of age-related macular degeneration in the Republic of Ireland

被引:36
作者
Akuffo, Kwadwo Owusu [1 ]
Nolan, John [1 ]
Stack, Jim [1 ]
Moran, Rachel [1 ]
Feeney, Joanne [2 ,3 ]
Kenny, Rose Anne [2 ]
Peto, Tunde [4 ,5 ]
Dooley, Cara [2 ]
O'Halloran, Aisling M. [2 ]
Cronin, Hilary [2 ]
Beatty, Stephen [1 ]
机构
[1] Waterford Inst Technol, Dept Chem & Life Sci, Macular Pigment Res Grp, Carriganore, Waterford, Ireland
[2] Trinity Coll Dublin, Dept Med Gerontol, Irish Longitudinal Study Ageing, Dublin, Ireland
[3] Queens Univ Belfast, Ctr Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland
[4] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England
[5] UCL Inst Ophthalmol, London, England
基金
欧洲研究理事会;
关键词
BLUE MOUNTAINS EYE; CLINICAL-TRIAL; MACULOPATHY; POPULATION;
D O I
10.1136/bjophthalmol-2014-305768
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Age-related macular degeneration (AMD) remains the most common cause of visual loss among subjects over 50 years of age in the developed world. The Irish Longitudinal study on Ageing (TILDA) is a population-based study of subjects aged 50 years or older, designed to investigate factors that influence ageing, and has enabled this investigation of the prevalence of AMD in the Republic of Ireland (ROI). Methods Data collected from a nationally representative sample of community-living older adults aged 50 years and over in ROI over the period November 2009 to July 2011. 5035 participants attended the TILDA health centre for assessment. Retinal photographs were obtained in 4859 of these participants. Retinal grading was performed in a masked fashion using a modified version of the International Classification and Grading System for AMD. Results Adjusting for lower response rates among older subjects, the estimated overall prevalence of any AMD was 7.2% (95% CI 6.5% to 7.9%) in the population aged 50 years or older. The estimated prevalence of early AMD was 6.6% (95% CI 5.9% to 7.3%), and the estimated prevalence of late AMD was 0.6% (95% CI 0.4% to 0.8%). Statistically significant associations with AMD included increasing age and family history of the condition. Conclusions This is the first study to provide prevalence estimates of AMD in ROI and will inform eye care professionals and policymakers involved in the delivery and planning of care for those afflicted with this condition.
引用
收藏
页码:1037 / 1044
页数:8
相关论文
共 29 条
  • [1] Prevalence of age-related maculopathy and age-related macular degeneration among the inuit in Greenland:: The Greenland Inuit Eye Study
    Andersen, Mads Varis Nis
    Rosenberg, Thomas
    la Cour, Morten
    Kulgaard, Jens F.
    Prause, Jan U.
    Alsbirk, Poul Helge
    Borch-Johnsen, Knut
    Peto, Tunde
    Carstensen, Bendix
    Bird, Alan C.
    [J]. OPHTHALMOLOGY, 2008, 115 (04) : 700 - 707
  • [2] Prevalence of age-related maculopathy in older Europeans - The European Eye Study (EUREYE)
    Augood, CA
    Vingerling, JR
    de Jong, PTVM
    Chakravarthy, U
    Seland, J
    Soubrane, G
    Tomazzoli, L
    Topouzis, F
    Bentham, G
    Rahu, M
    Vioque, J
    Young, IS
    Fletcher, AE
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (04) : 529 - 535
  • [3] AN INTERNATIONAL CLASSIFICATION AND GRADING SYSTEM FOR AGE-RELATED MACULOPATHY AND AGE-RELATED MACULAR DEGENERATION
    BIRD, AEC
    BRESSLER, NM
    BRESSLER, SB
    CHISHOLM, IH
    COSCAS, G
    DAVIS, MD
    DEJONG, PTVM
    KLAVER, CCW
    KLEIN, BEK
    KLEIN, R
    MITCHELL, P
    SARKS, JP
    SARKS, SH
    SOURBANE, G
    TAYLOR, HR
    VINGERLING, JR
    [J]. SURVEY OF OPHTHALMOLOGY, 1995, 39 (05) : 367 - 374
  • [4] Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010
    Bloch, Sara Brandi
    Larsen, Michael
    Munch, Inger Christine
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (02) : 209 - 213
  • [5] Brugiavini A, 2005, AGEING RETIREMENT EU
  • [6] Central Statistics Office, 2012, CENS 2011
  • [7] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    [J]. OPHTHALMOLOGY, 2012, 119 (07) : 1399 - 1411
  • [8] Lutein plus Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial
    Chew, Emily Y.
    Clemons, Traci E.
    SanGiovanni, John Paul
    Danis, Ronald
    Ferris, Frederick L., III
    Elman, Michael
    Antoszyk, Andrew
    Ruby, Alan
    Orth, David
    Bressler, Susan
    Fish, Gary
    Hubbard, Baker
    Klein, Michael
    Chandra, Suresh
    Blodi, Barbara
    Domalpally, Amitha
    Friberg, Thomas
    Wong, Wai
    Rosenfeld, Philip
    Agron, Elvira
    Toth, Cynthia
    Bernstein, Paul
    Sperduto, Robert
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (19): : 2005 - 2015
  • [9] Health and Aging: Development of The Irish Longitudinal Study on Ageing Health Assessment
    Cronin, Hilary
    O'Regan, Clare
    Finucane, Ciaran
    Kearney, Patricia
    Kenny, Rose Anne
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S269 - S278
  • [10] Racial differences in the prevalence of age-related macular degeneration - The Baltimore eye survey
    Friedman, DS
    Katz, J
    Bressler, NM
    Rahmani, B
    Tielsch, JM
    [J]. OPHTHALMOLOGY, 1999, 106 (06) : 1049 - 1055